Human Co115 colon carcinoma cells potentiate the degradation of laminin mediated by tissue-type plasminogen activator

Publisher Website
Google Scholar
Abstract
The plasminogen activation (PA) system of human Co 115 colon carcinoma cells was investigated. Analysis at the levels of protein and mRNA of cultured cells and of histozymography of tumor xenografts in nude mice showed that Co 115 cells produce only tissue type PA (t‐PA) and no urokinase (u‐PA). Also, mRNA for the u‐PA receptor and for PA inhibitorr type 2 (PAI‐2), but not for PAI‐I, were detected. We developed a quantitative degradation assay using glutaraldehyde‐immobilized125I‐Iaminin to investigate the capacity of Co 115 cells to degrade laminin. Laminin degradation by Co 115 cells was completely inhibited by 100 μg/ml of polyclonal anti‐t‐PA IgG, by the plasmin inhibitors aprotinin (100μg/ml) or ε‐aminocaproic acid (EACA; at 0.3 M), but not by antibodies against u‐PA or u‐PAR nor by nonimmune IgG. Cycloheximide‐treated Co 115 cells were unable to degrade laminin but increased laminin degradation induced by conditioned medium of Co 115 cells or recombinant t‐PA. No potentiation was observed when Co 115 cells and laminin were kept separated by Transwell™ inserts. Our results suggest that Co 115 human colon carcinoma cells degrade laminin by potentiating t‐PA‐mediated plasminogen activaton at the cells surface which requires close contact between tumor cells and laminin substrate.

This publication has 31 references indexed in Scilit: